To demonstrate that our anti-DLK1 mAb could be internalized efficiently, we quantified the cellular internalization rates of DLK1 antibody across ACC cell lines with varying DLK1 expression levels using imaging flow cytometry. The gene discussed is DLK1; the disease is adrenal cortex carcinoma.